Alector, Inc. — Earnings Quality Grade D
ALEC · Healthcare
Significant concerns
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
Insufficient data
Insufficient data
Revenue -79.1%, CFFO 20.0%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth -96.7% vs revenue -79.1%. Normal
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 1.29. Profits backed by cash
FCF is negative ($-0.2B)
Accruals ratio = 14.0%. Exceeds 10%
Cash $0.3B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Debt/EBITDA = -0.2x. Healthy
Other assets -65.1% vs revenue -79.1%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
No goodwill
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor ALEC continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25